
NuVasive NUVA
Country |
|
IPO year |
2004 |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
52 M |
Market Cap[1] |
$ 2.07 B |
EBITDA (LTM) |
$ 165 M |
P/E (LTM) |
- |
P/S (LTM) |
1.68 |
EPS (LTM) |
0.06 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
Myomo
MYO
|
$ 0.93 | -3.11 % | $ 38.9 M | NYSE American | ||
|
EDAP TMS S.A.
EDAP
|
- | - | $ 162 M | Nasdaq Global Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Profound Medical Corp.
PROF
|
$ 7.24 | -0.14 % | $ 219 M | Nasdaq Global Select Market | ||
|
AxoGen
AXGN
|
$ 41.37 | 0.53 % | $ 1.91 B | Nasdaq Capital Market,SPB | ||
|
Quanterix Corporation
QTRX
|
$ 3.38 | -3.15 % | $ 144 M | Nasdaq Global Select Market,SPB | ||
|
AVITA Medical
RCEL
|
$ 4.44 | -3.69 % | $ 124 M | Nasdaq Global Select Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Bruker Corporation
BRKR
|
$ 61.74 | -1.86 % | $ 9.37 B | Nasdaq Global Select Market,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Smith & Nephew plc
SNN
|
$ 32.66 | 0.31 % | $ 28.3 B | NYSE | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Tactile Systems Technology
TCMD
|
$ 27.4 | -1.23 % | $ 627 M | Nasdaq Global Select Market,SPB | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Tandem Diabetes Care
TNDM
|
$ 18.59 | 4.67 % | $ 1.26 B | Nasdaq Global Market,SPB | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
ClearPoint Neuro
CLPT
|
$ 14.14 | -2.68 % | $ 400 M | Nasdaq Capital Market | ||
|
IRIDEX Corporation
IRIX
|
$ 0.86 | -1.95 % | $ 14.6 M | Nasdaq Global Select Market | ||
|
Avanos Medical
AVNS
|
$ 24.99 | - | $ 1.16 B | NYSE,SPB | ||
|
Viemed Healthcare
VMD
|
$ 11.65 | -2.27 % | $ 453 M | Nasdaq Global Select Market | ||
|
Varex Imaging Corporation
VREX
|
$ 10.95 | -1.62 % | $ 453 M | Nasdaq Global Select Market,SPB | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.35 | -4.32 % | $ 21.8 M | Nasdaq Capital Market | ||
|
LENSAR
LNSR
|
$ 5.25 | -1.87 % | $ 62.8 M | Nasdaq Capital Market | ||
|
Beyond Air
XAIR
|
$ 5.51 | 0.92 % | $ 45.7 B | Nasdaq Global Select Market | ||
|
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | ||
|
Xtant Medical Holdings
XTNT
|
$ 0.43 | 0.14 % | $ 60 M | NYSE American | ||
|
Natus Medical Incorporated
NTUS
|
- | 1.94 % | $ 1.05 B | Nasdaq Global Select Market,SPB | ||
|
Nevro Corp.
NVRO
|
- | - | $ 217 M | NYSE,SPB | ||
|
Zimmer Biomet Holdings
ZBH
|
$ 97.15 | 1.46 % | $ 19.2 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.